Skip to main content
SpringerLink
Log in

P2 Receptors: Theoretical Background for the Use in Clinical Practice

  • Published:
Bulletin of Experimental Biology and Medicine Aims and scope

Abstract

Here we review the results of physiological, pharmacological, and pathophysiological studies of ATP receptors, P2 type receptors. Characteristics of two families of P2 receptors (P2X and P2Y) are presented and the possibility of using preparations affecting these receptors is discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. A. U. Ziganshin and L. E. Ziganshina, Pharmacology of Receptors for ATP [in Russian], Moscow (1999).

  2. M. P. Abbracchio and G. Burnstock, Pharmacol. Ther., 64, 445–475 (1994).

    Google Scholar 

  3. H. J. Agteresch, P. C. Dagnelie, J. W. van den Berg, et al., Drugs., 58, 211–232 (1999).

    Google Scholar 

  4. H. J. Agteresch, P. C. Dagnelie, A. van der Gaast, et al., J. Natl. Cancer Inst. 92, 321–328 (2000).

    Google Scholar 

  5. Y. Aso, A. Tajima, K. Suzuki, et al., Urology., 6, 512–520 (1986).

    Google Scholar 

  6. B. C. Bloor, A. F. Fukunaga, C. Ma, et al., Anesthesiology, 63, 517–525 (1985).

    Google Scholar 

  7. D. J. Boarini, N. F. Kassell, J. A. Sprowell, et al., Neurosurgery, 15, 325–331 (1984).

    Google Scholar 

  8. P. Bodin and G. Burnstock, Inflamm. Res., 47, 351–354 (1998).

    Google Scholar 

  9. J. Bogousslavsky, Cerebrovasc. Dis., 11,Suppl. 2, 5–10 (2001).

    Google Scholar 

  10. G. Buell, G. Collo, and F. Rassendren, Eur. J. Neurosci., 8, 2221–2228 (1996).

    Google Scholar 

  11. G. Burnstock, Pharmacol. Rev., 24, 509–581 (1972).

    Google Scholar 

  12. G. Burnstock, Cell membrane receptors for drugs and hormones: A multidisciplinary approach / Eds. R. W. Straub and L. Bolis, New York (1978) pp. 107–118.

  13. G. Burnstock, Neuropharmacology, 36, 1127–1139 (1997).

    Google Scholar 

  14. G. Burnstock, Prog. Brain Res., 120, 3–10 (1999).

    Google Scholar 

  15. G. Burnstock, Br. J. Anaesth., 84, 476–488 (2000).

    Google Scholar 

  16. G. Burnstock, Drug Dev. Res., 52, 1–10 (2001).

    Google Scholar 

  17. G. Burnstock, Handbook of experimental pharmacology / Eds. M. P. Abbrachio and M. Williams, Berlin (2001) pp. 423–515.

  18. G. Burnstock, Trends Pharm. Sci., 22, 182–188 (2001).

    Google Scholar 

  19. G. Burnstock and M. Williams, J. Pharmacol. Exp. Ther., 295, 862–869 (2000).

    Google Scholar 

  20. G. Burnstock and J. N. Wood, Curr. Opin. Neurobiol, 6,No. 4, 526–532 (1996).

    Google Scholar 

  21. D. A. Cockayne, S. G. Hamilton, Q. M. Zhu, et al., Nature, 407, 1011–1015 (2000).

    Google Scholar 

  22. G. Collo, S. Neidhart, E. Kawashima, et al., Neuropharmacology, 36, 1277–1283 (1997).

    Google Scholar 

  23. B. N. Cronstein, M. G. Bouma, and B. F. Becker, Drug Dev. Res., 39, 426–435 (1996).

    Google Scholar 

  24. R. A. Cunha and J. A. Ribeiro, Life Sci., 68, 119–137 (2000).

    Google Scholar 

  25. F. Di Virgilio, P. A. Borea, and P. Illes, Trends Pharmacol. Sci., 22, 5–7 (2001).

    Google Scholar 

  26. F. Di Virgilio, J. M. Sanz, P. Chiozzi, et al., Prog. Brain Res., 120, 355–370 (1999).

    Google Scholar 

  27. S. J. Dixon and S. M. Sims, Drug Dev. Res., 49, 187–200 (2000).

    Google Scholar 

  28. P. M. Dunn, Curr. Biol., 10, R305–R307 (2000).

    Google Scholar 

  29. P. M. Dunn, Y. Zhong, and G. Burnstock, Prog. Neurobiol., 65, 107–134 (2001).

    Google Scholar 

  30. J. E. Fabre, M. Nguyen, A. Latour, et al., Nat. Med., 5, 1199–1202 (1999).

    Google Scholar 

  31. S. Falzoni, M. Munirati, D. Ferrari, et al., J. Clin. Invest., 95, 1207–1216 (1995).

    Google Scholar 

  32. R. D. Fields and B. Stevens, Trends Neurosci., 23, 625–633 (2000).

    Google Scholar 

  33. B. B. Fredholm, G. Arslan, B. Kull, et al., Drug Dev. Res., 39, 262–268 (1996).

    Google Scholar 

  34. D. Hillaire-Buys, G. Bertrand, J. Chapal, et al., Br. J. Pharmacol., 109, 183–187 (1993).

    Google Scholar 

  35. S. Hourani, F. Di Virgilio and M. M. Loubattieres-Mariani, The P2 nucleotide receptors / Eds. J. T. Turner et al., Totowa (1998) pp. 361–411.

  36. P. P. A. Humphrey, G. Buell, I. Kennedy, et al., Naunyn-Schmiedeberg's Arch. Pharmacol., 352, 585–596 (1995).

    Google Scholar 

  37. B. S. Khakh, E. A. Barnard, G. Burnstock, et al., The IUPHAR compendium of receptor characterization and classification, London (2001) pp. 290–305.

  38. K. Inoue, Pharmacol. Res., 38, 323–331 (1998).

    Google Scholar 

  39. M. F. Jarvis, C. T. Wismer, E. Schweitzer, et al., Br. J. Pharmacol., 132, 259–269 (2001).

    Google Scholar 

  40. B. Jarvis and K. Simpson, Drugs, 60, 347–377 (2000).

    Google Scholar 

  41. K. Kichenin, S. Decollogne, J. Angignard, et al., J. Appl. Physiol., 88, 1962–1968 (2000).

    Google Scholar 

  42. B. F. King, A. Townsend-Nicholson, and G. Burnstock, Trends Pharmacol. Sci., 19, 506–514 (1998).

    Google Scholar 

  43. B. F. King, G. Burnstock, J. L. Boyer, et al., The IUPHAR compendium of receptor characterization and classification, London (2001) pp. 306–320.

  44. O. Korchazhkina, G. Wright, and C. Exley, Br. J. Pharmacol., 127, 701–708 (1999).

    Google Scholar 

  45. T. Matsumoto, T. Nakane, and S. Chiba, Eur. J. Pharmacol., 334, 173–180 (1997).

    Google Scholar 

  46. D. C. B. Mills, Thromb. Haemostas, 76, 835–856 (1996).

    Google Scholar 

  47. K. Mulryan, D. P. Gitterman, C. J. Lewis, et al., Nature, 403, 86–89 (2000).

    Google Scholar 

  48. J. T. Neary, M. P. Rathbone, F. Cattabeni, et al., Trends Neurosci., 19, 13–18 (1996).

    Google Scholar 

  49. R. A. North and A. Suprenant, Ann. Rev. Pharmacol. Toxicol., 40, 563–580 (2000).

    Google Scholar 

  50. S. Palea, W. Artibani, E. Ostardo, et al., J. Urol., 150, 2007–2012 (1993).

    Google Scholar 

  51. S. Palea, C. Pietra, D. G. Trist, et al., Br. J. Pharmacol., 114, 35–40 (1995)

    Google Scholar 

  52. T. M. Palmer and G. L. Stiles, Neuropharmacology, 34, 683–694 (1995).

    Google Scholar 

  53. J. Pintor, A. Peral, B. Navas, et al., Drug Dev. Res., 50, 22 (2000).

    Google Scholar 

  54. E. Rapaport, Ibid, 28, 428–431 (1993).

    Google Scholar 

  55. E. Rapaport, Purinergic approaches in experimental therapeutics / Eds. K. A. Jacobson and M. S. Jarvis, New York (1997) pp. 545–553.

  56. G. A. Rongen, J. S. Floras, J. W. M. Lenders, et al., Clin. Sci., 92, 13–24 (1997).

    Google Scholar 

  57. A. Suprenant, F. Rassendren, E. Kawashima, et al., Science, 272, 735–738 (1996).

    Google Scholar 

  58. R. J. Theobald, Life Sci., 56, 445–454 (1995).

    Google Scholar 

  59. A. Townsend-Nicholson, B. F. King, S. S. Wildman, et al., Brain Res. Mol. Brain Res., 64, 246–254 (1999).

    Google Scholar 

  60. G. Vassort, Physiol. Rev., 81, 767–806 (2001).

    Google Scholar 

  61. C. Z. Wang, N. Numba, T. Gonoi, et al., Biochem. Biophys. Res. Commun., 220, 196–202 (1996).

    Google Scholar 

  62. S. L. Wilbur and F. E. Marchlinski, Am. J. Cardiol., 79,No. 12A, 30–37 (1997).

    Google Scholar 

  63. A. U. Ziganshin, C. H. V. Hoyle, and Burnstock G., Drug Dev. Res., 32, 134–146 (1994).

    Google Scholar 

  64. A. U. Ziganshin, A. P. Zaitcev, N. V. Golovanova, et al., Ibid, 50, 105 (2000).

    Google Scholar 

  65. L. E. Ziganshina, A. U. Ziganshin, C. H. V. Hoyle, et al., Inflamm. Res., 45, 96–102 (1996).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, Kazan State Medical University, Russia

    A. U. Ziganshin, L. E. Ziganshina & G. Burnstock

  2. Department of Clinical Pharmacology, Kazan State Medical Academy, Russia

    A. U. Ziganshin, L. E. Ziganshina & G. Burnstock

  3. Autonomic Neuroscience Institute, University College, London

    A. U. Ziganshin, L. E. Ziganshina & G. Burnstock

Authors
  1. A. U. Ziganshin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. E. Ziganshina
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. G. Burnstock
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ziganshin, A.U., Ziganshina, L.E. & Burnstock, G. P2 Receptors: Theoretical Background for the Use in Clinical Practice. Bulletin of Experimental Biology and Medicine 134, 313–317 (2002). https://doi.org/10.1023/A:1021921824876

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1021921824876

Search

Navigation